Published in Am J Clin Nutr on February 01, 2007
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Myofibrillar protein synthesis following ingestion of soy protein isolate at rest and after resistance exercise in elderly men. Nutr Metab (Lond) (2012) 1.02
Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis. J Cyst Fibros (2013) 0.93
Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion. Clin Nutr (2013) 0.93
Enhanced anabolic response to milk protein sip feeding in elderly subjects with COPD is associated with a reduced splanchnic extraction of multiple amino acids. Clin Nutr (2012) 0.91
Amino acid metabolism and regulatory effects in aging. Curr Opin Clin Nutr Metab Care (2008) 0.88
Role of Ingested Amino Acids and Protein in the Promotion of Resistance Exercise-Induced Muscle Protein Anabolism. J Nutr (2016) 0.86
Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis (2010) 0.86
Nutrition and respiratory health--feature review. Nutrients (2015) 0.84
Multidisciplinary team-based approach for comprehensive preoperative pulmonary rehabilitation including intensive nutritional support for lung cancer patients. PLoS One (2013) 0.83
Casein protein results in higher prandial and exercise induced whole body protein anabolism than whey protein in chronic obstructive pulmonary disease. Metabolism (2012) 0.81
Role of specific dietary amino acids in clinical conditions. Br J Nutr (2012) 0.79
Undernutrition in patients with COPD and its treatment. Nutrients (2013) 0.78
Short-term protein intake increases fractional synthesis rate of muscle protein in the elderly: meta-analysis. Nutr Res Pract (2010) 0.77
Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease. Am J Clin Nutr (2016) 0.76
Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization. J Nutr Metab (2011) 0.75
Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults. Metabolism (2016) 0.75
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr (2004) 7.24
Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70
Systemic effects of smoking. Chest (2007) 3.63
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 3.54
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest (2003) 2.90
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology (2004) 2.69
Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51
Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest (2014) 2.27
Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20
Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A (2004) 2.19
Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest (2004) 2.08
Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer (2006) 2.07
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation. Eur Respir J (2013) 2.05
Inaccuracy of estimating peak work rate from six-minute walk distance in patients with COPD. COPD (2012) 1.98
Pulmonary function in diabetes: a metaanalysis. Chest (2010) 1.96
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79
Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.76
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc (2015) 1.72
Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol (2002) 1.71
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition (2003) 1.60
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax (2011) 1.60
Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology (2002) 1.60
Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone (2012) 1.56
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy. Am J Physiol Cell Physiol (2011) 1.55
Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther (2013) 1.54
Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med (2005) 1.54
Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J (2004) 1.53
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med (2006) 1.50
L-arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit Care Med (2002) 1.50
The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med (2014) 1.49
Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med (2009) 1.49
Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure. J Pediatr (2013) 1.49
Measuring body composition in chronic heart failure: a comparison of methods. Eur J Heart Fail (2005) 1.48
Measuring whole-body actin/myosin protein breakdown in mice using a primed constant stable isotope-infusion protocol. Clin Sci (Lond) (2003) 1.45
Acute effects of breakfasts containing alpha-lactalbumin, or gelatin with or without added tryptophan, on hunger, 'satiety' hormones and amino acid profiles. Br J Nutr (2008) 1.43
The last wish of a patient with end stage chronic obstructive pulmonary disease. BMJ (2008) 1.41
Reference values for vastus lateralis fiber type proportions and fiber size. J Appl Physiol (1985) (2013) 1.40
Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. J Hepatol (2008) 1.39
Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care (2010) 1.35
Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr (2008) 1.35
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax (2007) 1.32
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med (2010) 1.30
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc (2011) 1.28
In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta (2006) 1.27
The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers. Psychopharmacology (Berl) (2006) 1.26
Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav (2009) 1.26
Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol (2006) 1.25
Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys (2003) 1.24
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med (2011) 1.23
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax (2013) 1.20
Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology (2006) 1.20
Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol (2002) 1.19
Systemic effects in COPD. Chest (2002) 1.19
Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med (2003) 1.17
Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol (2005) 1.17
Telomere shortening in chronic obstructive pulmonary disease. Respir Med (2008) 1.16
Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.16
Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. Cancer Epidemiol Biomarkers Prev (2002) 1.16
Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD (2006) 1.15
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer (2005) 1.14
Increased systemic inflammation is a risk factor for COPD exacerbations. Chest (2008) 1.12
Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest (2003) 1.12
Integration of pulmonary rehabilitation in COPD. Lancet (2008) 1.11
Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res (2010) 1.11
Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol (2004) 1.09
Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med (2012) 1.09
Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis (2010) 1.08
Exogenous arginine in sepsis. Crit Care Med (2007) 1.07
Glutamine is an important precursor for de novo synthesis of arginine in humans. Am J Clin Nutr (2008) 1.07
Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab (2012) 1.06
The metabolic response during resistance training and neuromuscular electrical stimulation (NMES) in patients with COPD, a pilot study. Respir Med (2008) 1.06
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet (2009) 1.06
Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr (2007) 1.06
Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am J Clin Nutr (2004) 1.05
Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med (2011) 1.05